Rep.-elect Luke Letlow (R-La.), who was hospitalized for COVID-19 on Saturday, has been transferred to an intensive care unit (ICU) in Louisiana, a spokesperson for Letlow confirmed to The Hill on Wednesday.
The congressman-elect is now in stable condition in the ICU at Ochsner LSU Health in Shreveport, La. He is receiving the antiviral medication remdesivir and steroids to help combat the virus, according to G.E. Ghali, chancellor of the Shreveport Academic Medical Center.
Letlow tested positive for the coronavirus on Friday and was admitted to St. Francis Medical Center in Monroe, La., the following day as a "precaution," according to Andrew Bautsch, a spokesman for the Louisiana Republican.
Letlow won the Pelican State's 5th District seat during the Dec. 5 runoff race.
President TrumpDonald TrumpKinzinger says Trump 'winning' because so many Republicans 'have remained silent' Our remote warfare counterterrorism strategy is more risk than reward Far-right rally draws small crowd, large police presence at Capitol MORE and his personal attorney Rudy GiulianiRudy GiulianiRoger Stone served with Capitol riot lawsuit during radio interview FEC finds Twitter didn't break law by blocking spread of Hunter Biden story Juan Williams: The toxic legacy of Trump's corruption MORE both received remdesivir during their COVID-19 infections. However, the World Health Organization recommended against it as a treatment for the virus in November due to a lack of evidence that it increases survival rates among COVID-19 patients.
In a statement released on Wednesday by Bautsch, the spokesman said that Letlow and his family deeply appreciate the medical care he has gotten and are "thankful for all of the prayers and support they continue to receive."
Luke Letlow (@LukeLetlow) December 23, 2020